Ensign Group IncENSG
Price$169.63Intrinsic value$177.685% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $177.68median of 6 methods · middle span $119-$318based on filings through 30 Jun 2026
Market Price $169.63Price as of 1 Oct 2026
Margin of Safety +4.8%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 15.1% (near-term consensus, capped) · years 2–5: 11.9%/yr (balance of the path).12.5% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 612.0%Yr 712.2%Yr 812.3%Yr 912.4%Yr 1012.5%
11.9% → 12.5%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1111.6%Yr 1210.6%Yr 139.7%Yr 148.7%Yr 157.8%Yr 166.8%Yr 175.9%Yr 184.9%Yr 194.0%Yr 203.0%
12.5% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)19.3%
Discount rate (cost of equity) 8.5%
Volatility vs market (adjusted beta)0.79

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetEnsign Group IncENSGHealth Care
Valuation
P/E26.6×
P/S1.9×
P/B4.3×
EV / Revenue1.9×
EV / EBITDA17.9×
Profitability
Gross margin—
Operating margin9.0%
Net margin6.9%
FCF margin—
Returns
ROE15.5%
ROA6.6%
ROIC16.3%
Growth
Revenue growth (YoY)28.8%
5-yr fwd EPS growth12.5%
Financial strength
Debt / Equity0.06×
Current ratio1.21×
Altman Z-Score3.6
Interest coverage—
Dividend yield0.1%

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.